Inflammation and Immunity Gene Expression Patterns and Machine Learning Approaches in Association with Response to...

Area of Science:

• Oncology
• Immunology
• Genetics

Background:

• Clear cell renal cell carcinoma (ccRCC) is the most prevalent kidney cancer.
• Despite advances in targeted therapies and immune checkpoint inhibition (ICI), cures for metastatic ccRCC (mccRCC) remain infrequent.
• Optimal utilization of novel therapeutic agents requires predictive biomarkers for treatment efficacy.

Purpose of the Study:

• To explore mRNA expression profiles of inflammation and immunity-related circulating genes in mccRCC.
• To identify potential biomarkers for predicting response to ICI-based treatments.
• To develop a classification model for patient stratification based on gene expression.

Main Methods:

• Utilized RT2 profiler PCR Array (human cancer inflammation and immunity crosstalk kit) to assess gene mRNA expression.
• Analyzed differential gene expression between patients with clinical benefit and those who progressed on treatment.
• Employed machine learning approaches for sample classification.

Main Results:

• Identified several differentially expressed mRNAs in mccRCC patients who responded to treatment versus those who progressed.
• Demonstrated that gene expression profiles can accurately classify patient response to ICI therapy.
• Achieved high accuracy and specificity in sample classification based on identified mRNA signatures.

Conclusions:

• Circulating immune and inflammation-related gene expression profiles hold promise as predictive biomarkers for ICI therapy in mccRCC.
• Gene expression analysis, coupled with machine learning, can effectively stratify mccRCC patients for immunotherapy.
• Further validation of these biomarkers could optimize treatment selection and improve outcomes for mccRCC patients.